Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 08, 2024

BUY
$203.52 - $273.43 $154,675 - $207,806
760 New
760 $205,000
Q1 2023

May 01, 2023

BUY
$191.89 - $259.92 $193,041 - $261,479
1,006 New
1,006 $203,000
Q1 2022

Apr 26, 2022

SELL
$255.51 - $362.11 $483,680 - $685,474
-1,893 Closed
0 $0
Q4 2021

Jan 31, 2022

BUY
$351.38 - $448.68 $397,410 - $507,457
1,131 Added 148.43%
1,893 $713,000
Q3 2021

Nov 09, 2021

BUY
$372.64 - $458.3 $283,951 - $349,224
762 New
762 $314,000

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $10.1B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Ieq Capital, LLC Portfolio

Follow Ieq Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ieq Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ieq Capital, LLC with notifications on news.